Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...

Until now. Backed by more than six years of dedicated research and development in biosensing technology, Ottai has released a ...

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today provided a ...

Tracky introduces integrated real-time monitoring platform to track patient outcomes for GLP-1 therapies in India: Our Bureau, Mumbai Wednesday, March 25, 2026, 16:15 Hrs [IST] Dr ...

A major new study investigating the safest and most effective way to monitor blood sugar levels during labour in women with gestational diabetes has ...

Advances in microfluidic biosensors and materials science transformed sweat into a reliable, high-quality data stream capable ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Glucotrack Inc. (GCTK) shares soared nearly 15% in Friday’s pre-market trade after the company announced that it is in a ...

Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now. Following encouraging results from ...